Back to search
Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Activated PI3Kdelta Syndrome (APDS); PASLI Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Activated PI3Kdelta Syndrome (APDS); PASLI Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is designed to provide long-term CDZ173 treatment, a selective PI3Kδ inhibitor, to the patients with genetically activated PI3Kδ, i.e., patients with…
The purpose of this proposed research is to evaluate the efficacy and safety of the rapamycin therapy in patients with activated phosphoinositide 3-kinase δ syn…
This study was designed to explore CDZ173, a selective PI3Kδ inhibitor, in patients with genetically activated PI3Kδ, i.e., patients with Activated phosphoinosi…